Clinical Trials Logo

Clinical Trial Details — Status: Not yet recruiting

Administrative data

NCT number NCT06384898
Other study ID # STUDY00002259
Secondary ID UH3AT012413
Status Not yet recruiting
Phase N/A
First received
Last updated
Start date September 2024
Est. completion date October 2027

Study information

Verified date May 2024
Source Tufts Medical Center
Contact Chenchen Wang, MD, MSc
Phone 617-636-3251
Email Chenchen.Wang@tuftsmedicine.org
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The goal of this pragmatic randomized trial is to evaluate the effectiveness of remote Tai Chi to treat knee pain in adults with knee osteoarthritis. The main questions the trial aims to answer are: - Does remote Tai Chi improve the extent to which pain interferes with physical, mental, and social activities (PROMIS-Pain Interference at 3 months, primary outcome), as well as knee pain and function (WOMAC subscales) and analgesic use (secondary outcomes) - Does remote tai chi decreases healthcare utilization? Researchers will compare remote Tai Chi added to routine care to routine care alone to see if remote tai chi works to treat knee osteoarthritis pain. Participants will participate in remotely delivered web-based tai chi sessions, twice a week for 12 weeks, or will continue to receive routine care. Participants will be followed for 12 months after randomization.


Description:

Investigators will conduct a 12-month embedded, pragmatic, hybrid type 1 effectiveness-implementation, individually randomized group-treatment trial that will compare the effects of a 3-month twice weekly remotely delivered web-based Tai Chi intervention plus routine care versus routine care alone across four health care systems (Tufts Medical Center, Boston Medical Center, University of California Los Angeles Health, and Cleveland Clinic) in four geographic regions (Eastern Massachusetts, Southern California, Northeast Ohio (Cleveland Clinic), Southern Florida (Cleveland Clinic). Investigators will enroll a total of 480 diverse patients with a clinical diagnosis of Knee OA. Participants will be evaluated at baseline and 3 months, with additional follow-up at 6 and 12 months.


Recruitment information / eligibility

Status Not yet recruiting
Enrollment 480
Est. completion date October 2027
Est. primary completion date December 2026
Accepts healthy volunteers No
Gender All
Age group 50 Years to 100 Years
Eligibility Inclusion Criteria: - Age 50 years or older - Treating clinician diagnosis of knee osteoarthritis - PROMIS Pain Interference Short Form 6b; score 4 or 5 on at least 1 of 6 questions (possible answers to each question range from 1 to 5) - Able to provide informed consent - If randomized to the Routine Care group, willing to abstain from Tai Chi programs until completion of the study - Has access to a home computer or device that will allow telehealth delivery of the intervention - Is an active patient at one of the 4 participating healthcare system Exclusion Criteria: - Currently practicing Tai Chi - Serious medical conditions (e.g., dementia, significant neurological deficits or neurodegenerative disorder, active cancer treatment, psychosis, sensory deficits) limiting the participant's ability to participate in the Tai Chi safely, as determined by the principal investigators - Unable to walk without a cane or other assistive device - Any previous reconstructive surgery - Beck Depression Inventory (BDI-II) suicide item (#9) score 2 or 3 ('I would like to kill myself' or 'I would kill myself if I had the chance') - Not English speaking - Enrollment in any other clinical trial within the last 30 days

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Remote Tai Chi
Tai Chi mind-body exercise is a complex, multi-component nonpharmacological intervention integrating physical, psychological, emotional, and behavioral elements.

Locations

Country Name City State
United States Tufts Medical Center Boston Massachusetts

Sponsors (5)

Lead Sponsor Collaborator
Tufts Medical Center Boston Medical Center, National Center for Complementary and Integrative Health (NCCIH), The Cleveland Clinic, University of California, Los Angeles

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Other WOMAC Pain Score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm. 3 months from randomization
Other WOMAC Pain Score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm. 6 months from randomization
Other WOMAC Pain Score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm. 12 months from randomization
Other WOMAC Pain Score on nominated activity chosen at baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm.(Considering ALL the ways Knee PAIN affects participants, which activity is most important to participants today?) 3 months from randomization
Other WOMAC Pain Score on nominated activity chosen at baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm.(Considering ALL the ways Knee PAIN affects participants, which activity is most important to participants today?) 6 months from randomization
Other WOMAC Pain Score on nominated activity chosen at baseline Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain score rated on a Visual Analog Scale (VAS) of 0-100 mm.(Considering ALL the ways Knee PAIN affects participants, which activity is most important to participants today?) 12 months from randomization
Other WOMAC function score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function score rated on a Visual Analog Scale (VAS) of 0-100 mm. 3 months from randomization
Other WOMAC function score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function score rated on a Visual Analog Scale (VAS) of 0-100 mm. 6 months from randomization
Other WOMAC function score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) function score rated on a Visual Analog Scale (VAS) of 0-100 mm. 12 months from randomization
Other WOMAC stiffness score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness score rated on a Visual Analog Scale (VAS) of 0-100 mm. 3 months from randomization
Other WOMAC stiffness score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness score rated on a Visual Analog Scale (VAS) of 0-100 mm. 6 months from randomization
Other WOMAC stiffness score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) stiffness score rated on a Visual Analog Scale (VAS) of 0-100 mm. 12 months from randomization
Other Patient's global assessment score VAS 0-100 3 months from randomization
Other Patient's global assessment score VAS 0-100 6 months from randomization
Other Patient's global assessment score VAS 0-100 12 months from randomization
Other PROMIS sleep disturbance OA Knee- Short Form 6a PROMIS sleep disturbance OA knee raw score ranges between 6-30 and the T score ranges between 29.8-76.1, with higher scores indicates greater sleep disturbance. 3 months from randomization
Other PROMIS sleep disturbance OA Knee- Short Form 6a PROMIS sleep disturbance OA knee raw score ranges between 6-30 and the T score ranges between 29.8-76.1, with higher scores indicates greater sleep disturbance. 6 months from randomization
Other PROMIS sleep disturbance OA Knee- Short Form 6a PROMIS sleep disturbance OA knee raw score ranges between 6-30 and the T score ranges between 29.8-76.1, with higher scores indicates greater sleep disturbance. 12 months from randomization
Other Beck Depression Inventory-II score The Beck Depression Inventory-II score ranges between 0-63, with higher scores indicating more severe depression symptoms. 3 months from randomization
Other Beck Depression Inventory-II score The Beck Depression Inventory-II score ranges between 0-63, with higher scores indicating more severe depression symptoms. 6 months from randomization
Other Beck Depression Inventory-II score The Beck Depression Inventory-II score ranges between 0-63, with higher scores indicating more severe depression symptoms. 12 months from randomization
Other SF-12 MCS score The SF-12 Mental Component Score ranges between 0-100. 3 months from randomization
Other SF-12 MCS score The SF-12 Mental Component Score ranges between 0-100. 6 months from randomization
Other SF-12 MCS score The SF-12 Mental Component Score ranges between 0-100. 12 months from randomization
Other Receipt of knee surgery Number of Participants who receive knee surgery. 12 months from randomization
Other OMERACT/OARSI responder Number of participants who meet the OMERACT/OARSI responder criteria 3 months from randomization
Other OMERACT/OARSI responder Number of participants who meet the OMERACT/OARSI responder criteria 6 months from randomization
Other OMERACT/OARSI responder Number of participants who meet the OMERACT/OARSI responder criteria 12 months from randomization
Other Pain medication use 3 months from randomization
Other Pain medication use 6 months from randomization
Other Pain medication use 12 months from randomization
Primary PROMIS Pain Interference score The PROMIS Pain Interference short form 6b evaluates the extent to which pain interferes with physical, emotional and social activities. The raw score ranges between 6-30 and the T score ranges between 41.0-78.3, with higher scores indicating that pain has a greater negative impact. 3 months from randomization
Secondary WOMAC total score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score calculated by summing the pain, stiffness, and physical function subscales, rated on a Visual Analog Scale (VAS) of 0-100 mm. 3 months from randomization
Secondary WOMAC total score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score calculated by summing the pain, stiffness, and physical function subscales, rated on a Visual Analog Scale (VAS) of 0-100 mm. 6 months from randomization
Secondary WOMAC total score Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) total score calculated by summing the pain, stiffness, and physical function subscales, rated on a Visual Analog Scale (VAS) of 0-100 mm. 12 months from randomization
Secondary SF-12 PCS score The 12-item Short Form Health Survey (SF-12) has two summary scales, the Mental Health Component Score (MCS) and the Physical Component Score (PCS). Both scores range from 0 to 100, with higher scores indicating better mental and physical health. 3 months from randomization
Secondary SF-12 PCS score The 12-item Short Form Health Survey (SF-12) has two summary scales, the Mental Health Component Score (MCS) and the Physical Component Score (PCS). Both scores range from 0 to 100, with higher scores indicating better mental and physical health. 6 months from randomization
Secondary SF-12 PCS score The 12-item Short Form Health Survey (SF-12) has two summary scales, the Mental Health Component Score (MCS) and the Physical Component Score (PCS). Both scores range from 0 to 100, with higher scores indicating better mental and physical health. 12 months from randomization
Secondary Number of knee joint injections Total number of intra-articular injections identified through EHR and patient questionnaires. 12 months from randomization
Secondary PROMIS Pain Interference score The PROMIS Pain Interference short form 6b evaluates the extent to which pain interferes with physical, emotional and social activities. The raw score ranges between 6-30 and the T score ranges between 41.0-78.3, with higher scores indicating that pain has a greater negative impact. 6 months from randomization
Secondary PROMIS Pain Interference score The PROMIS Pain Interference short form 6b evaluates the extent to which pain interferes with physical, emotional and social activities. The raw score ranges between 6-30 and the T score ranges between 41.0-78.3, with higher scores indicating that pain has a greater negative impact. 12 months from randomization
See also
  Status Clinical Trial Phase
Recruiting NCT04651673 - Prescribed Knee Brace Treatments for Osteoarthritis of the Knee (Knee OA)
Completed NCT05677399 - Knee Osteoarthritis Treatment With Peloidotherapy and Aquatic Exercise. N/A
Active, not recruiting NCT04043819 - Evaluation of Safety and Exploratory Efficacy of an Autologous Adipose-derived Cell Therapy Product for Treatment of Single Knee Osteoarthritis Phase 1
Recruiting NCT06000410 - A Study to Evaluate the Efficacy of Amniotic Suspension Allograft in Patients With Osteoarthritis of the Knee Phase 3
Completed NCT05014542 - Needling Techniques for Knee Osteoarthritis N/A
Recruiting NCT05892133 - Prehabilitation Effect on Function and Patient Satisfaction Following Total Knee Arthroplasty N/A
Recruiting NCT05528965 - Parallel Versus Perpendicular Technique for Genicular Radiofrequency N/A
Active, not recruiting NCT03472300 - Prevalence of Self-disclosed Knee Trouble and Use of Treatments Among Elderly Individuals
Active, not recruiting NCT02003976 - A Randomized Trial Comparing High Tibial Osteotomy Plus Non-Surgical Treatment and Non-Surgical Treatment Alone N/A
Active, not recruiting NCT04017533 - Stability of Uncemented Medially Stabilized TKA N/A
Completed NCT04779164 - The Relation Between Abdominal Obesity, Type 2 Diabetes Mellitus and Knee Osteoarthritis N/A
Recruiting NCT04006314 - Platelet Rich Plasma and Neural Prolotherapy Injections in Treating Knee Osteoarthritis N/A
Recruiting NCT05423587 - Genicular Artery Embolisation for Knee Osteoarthritis II N/A
Enrolling by invitation NCT04145401 - Post Market Clinical Follow-Up Study- EVOLUTION® Revision CCK
Active, not recruiting NCT03781843 - Effects of Genicular Nerve Block in Knee Osteoarthritis N/A
Recruiting NCT05974501 - Pre vs Post Block in Total Knee Arthroplasty (TKA) Phase 4
Completed NCT05324163 - Evaluate Efficacy and Safety of X0002 in Treatment of Knee Osteoarthritis Phase 3
Completed NCT05529914 - Effects of Myofascial Release and Neuromuscular Training for Pes Anserine Syndrome Associated With Knee Osteoarthritis N/A
Recruiting NCT05693493 - Can Proprioceptive Knee Brace Improve Functional Outcome Following TKA? N/A
Not yet recruiting NCT05510648 - Evaluation of the Effect of High-intensity Laser Therapy in Knee Osteoarthritis N/A